Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Total Liabilities 2021–2025
Kiniksa Pharmaceuticals International, plc annual total liabilities history from 2021 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Kiniksa Pharmaceuticals International, plc total liabilities as of December 31, 2025: 196.0M, a 37.93% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc total liabilities for 2025 were 196.0M, a 37.93% increase from 2024.
- Kiniksa Pharmaceuticals International, plc total liabilities for 2024 were 142.1M, a 62.45% increase from 2023.
- Kiniksa Pharmaceuticals International, plc total liabilities for 2023 were 87.5M, a 37.72% increase from 2022.
- Kiniksa Pharmaceuticals International, plc total liabilities for 2022 were 63.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kiniksa Pharmaceuticals International, plc Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $196 |
| 2024 | $142 |
| 2023 | $87 |
| 2022 | $64 |
| 2021 | $48 |
Kiniksa Pharmaceuticals International, plc Total Liabilities — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KNSA's total liabilities history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's total liabilities by year and by quarter, including the growth rate.